Inhibition of Brd4 alleviates osteoarthritis pain via suppression of neuroinflammation and activation of Nrf2‐mediated antioxidant signalling
Jia Sun(Union Hospital), Wei Mei(Tongji Hospital), Dai-Qiang Liu(Tongji Hospital), Longqing Zhang(Tongji Hospital), Xinghe Wang(Beijing Shijitan Hospital), Jiayi Wu(Tongji Hospital), Fan‐He Song(Tongji Hospital), Liwei Wang(Renji Hospital), Danyang Li(Qilu Hospital of Shandong University), Shao‐Jie Gao(Tongji Hospital), Ya‐Qun Zhou(Tongji Hospital)
Cited by 17
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia
|Clinical Infectious Diseases|2020|138
PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
|Current Pharmaceutical Design|2017|126